School of Medicine


Showing 101-150 of 244 Results

  • Alan M Glaseroff

    Alan M Glaseroff

    Adjunct Professor, Medicine - Primary Care and Population Health

    BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.

    Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.

    The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.

    Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB

  • Jeffrey S.  Glenn, M.D., Ph.D.

    Jeffrey S. Glenn, M.D., Ph.D.

    Joseph D. Grant Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.

  • Giancarlo Glick

    Giancarlo Glick

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.

  • Ira D Glick

    Ira D Glick

    Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.

  • Gary Glover

    Gary Glover

    Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Psychology and of Electrical Engineering

    Current Research and Scholarly InterestsMy present research is devoted to the advancement of functional magnetic resonance imaging sciences for applications in basic understanding of the brain in health and disease. We collaborate closely with departmental clinicians and with others in the school of medicine, humanities, and the engineering sciences.

  • Anna L Gloyn

    Anna L Gloyn

    Professor of Pediatrics (Endocrinology) and of Genetics

    Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.

  • Gopi Shah Goda

    Gopi Shah Goda

    Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics and of Health Policy

    BioGopi Shah Goda is a Senior Fellow at the Stanford Institute for Economic Policy Research (SIEPR), Associate Professor of Health Policy (by courtesy) and Professor of Economics (by courtesy) at Stanford University. Gopi served as a senior economist at the White House Council of Economic Advisers from July 2021 to July 2022. She is also a Faculty Research Fellow at the National Bureau of Economic Research, a Fellow of the Society of Actuaries, and served as SIEPR's Deputy Director from September 2016 to July 2021.

    Gopi’s research focuses on the well-being of individuals as they age, the sustainability of public programs serving elderly and vulnerable populations, and the broader implications of the COVID-19 pandemic on health and labor supply. Her recent research studies examine the effects of long-term care insurance on family members’ work and location decisions, and how COVID-19 illness affects U.S. workers. Her work has appeared in a variety of leading economics journals, and has and has garnered coverage in major media outlets such as the Wall Street Journal, the New York Times, the Washington Post, National Public Radio, the Guardian, and the San Francisco Chronicle. Gopi's research has been supported by the Social Security Administration, the National Institutes on Aging, the Alfred P. Sloan Foundation and the TIAA Institute.

    Prior to joining SIEPR, Gopi was a Robert Wood Johnson Scholar in Health Policy Research at Harvard University. She earned her PhD in economics from Stanford University in 2007 and her B.S. in mathematics and actuarial science from the University of Nebraska – Lincoln in 2000.

  • Aparna Goel

    Aparna Goel

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.

    She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others.

  • Lauren Goins

    Lauren Goins

    Assistant Professor of Developmental Biology

    Current Research and Scholarly InterestsThe Goins lab aims to understand how cells make decisions. Our research focuses on how young, immature blood stem cells, with the potential to become many different cell types, choose between these cell fates.

  • Carl Gold

    Carl Gold

    Clinical Associate Professor, Neurology & Neurological Sciences
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Gold is a board-certified neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold's primary research interest focuses on enhancing the communication skills of neurology residents, and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.

    Dr. Gold serves as Vice Chair of Quality, Safety, & Experience for the Department of Neurology & Neurological Sciences. In this role, he coordinates projects aimed at improving care for patients with neurological conditions across the health system.

    For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html

    Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html

    Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html

  • Garry Gold

    Garry Gold

    Stanford Medicine Professor of Radiology and Biomedical Imaging

    Current Research and Scholarly InterestsMy primary focus is application of new MR imaging technology to musculoskeletal problems. Current projects include: Rapid MRI for Osteoarthritis, Weight-bearing cartilage imaging with MRI, and MRI-based models of muscle. We are studying the application of new MR imaging techniques such as rapid imaging, real-time imaging, and short echo time imaging to learn more about biomechanics and pathology of bones and joints. I am also interested in functional imaging approaches using PET-MRI.

  • Jeffrey Goldberg, MD, PhD

    Jeffrey Goldberg, MD, PhD

    Blumenkranz Smead Professor

    Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.

  • Olga Fedin Goldberg

    Olga Fedin Goldberg

    Clinical Associate Professor, Neurology & Neurological Sciences

    BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.

  • Neville H. Golden M.D.

    Neville H. Golden M.D.

    Marron and Mary Elizabeth Kendrick Professor of Pediatrics, Emeritus

    Current Research and Scholarly InterestsMy research has focused on the medical complications of adolescents with eating disorders. My specific area of study has been the etiology and implications of amenorrhea in adolescents with eating disorders, in particular the management of reduced bone mass and osteoporosis in anorexia nervosa.

  • David Edward Goldenberg

    David Edward Goldenberg

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr Goldenberg completed training at UCLA, Geisel School of Medicine at Dartmouth, Tufts Medical Center, and Cedars Sinai Medical Center. In addition to a gastroenterology fellowship, he graduated with a Masters in Healthcare Delivery Science at Cedars Sinai Medical Center. He has a passion for medical education and enjoys teaching medical students, residents, and fellows as a Clinician Educator. His research focuses on Healthcare Delivery with an emphasis on maximizing value-based healthcare and medical innovation. He has an additional interest in translational research with multiple publications and patent applications for medical devices. He has unique clinical expertise in fecal microbiota transplantation.

  • Jeremy Goldhaber-Fiebert

    Jeremy Goldhaber-Fiebert

    Professor of Health Policy

    BioJeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy and a Core Faculty Member in the Centers for Health Policy and Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021.

    Past and current research topics:

    - Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.

    -Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.

    - Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.

    - Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.

    - Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity.

  • Sara Goldhaber-Fiebert

    Sara Goldhaber-Fiebert

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsMy teams' interests are in improving patient safety, harnessing implementation science and medical simulation techniques for training, development, dissemination, implementation and study of these processes. We collaborate nationally and globally on implementation of emergency manuals (context relevant sets of cognitive aids or crisis checklists), for management of crises and freely share team training resources. See http://emergencymanual.stanford.edu and www.emergencymanuals.org

  • Shelley Goldman

    Shelley Goldman

    Associate Dean for Faculty Affairs and for Student Affairs and Professor (Teaching) of Education, Emerita

    Current Research and Scholarly InterestsUse and integration of digital technologies for teaching and learning; learning in informal settings, especially learning mathematics and science within families; bringing the tools and mindsets of design thinking to K-12 classrooms and to broadening STEM participation.

  • Mary Kane Goldstein

    Mary Kane Goldstein

    Professor of Health Policy, Emerita

    Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities

  • Andrea Goldstein-Piekarski

    Andrea Goldstein-Piekarski

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.

    As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.

    This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health.

  • Natalia Gomez-Ospina

    Natalia Gomez-Ospina

    Assistant Professor of Pediatrics (Genetics) and of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.

    1) Lysosomal storage diseases:
    Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease


    2) Point of care ammonia testing
    She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.

    3) Gene discovery
    Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.


    For more information go to our website:

    https://www.gomezospina.com/

  • Julie Good, MD

    Julie Good, MD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsJulie's academic interests include pediatric palliative care, pain and symptom management for children with life-threatening illness, medical acupuncture, and meaning in medicine (the humanistic side of doctoring)

  • Alex J Goodell

    Alex J Goodell

    Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine

    BioAnesthesiologist and internist interested in artificial intelligence, design thinking in healthcare, open-source technology, and epidemiology.

    I am currently a fellow in the Anesthesia Informatics and Media Lab where I focus on building tools to improve the user experience of patients and doctors. My current projects include medical usability analysis, evaluation of artificial intelligence, and improving real-time data access for anesthesiologists.

    I completed medical school at the UC Berkeley - UCSF Joint Medical Program, followed by the Combined Internal Medicine/Anesthesiology Residency at the Stanford School of Medicine.

  • Miriam B. Goodman

    Miriam B. Goodman

    Mrs. George A. Winzer Professor of Cell Biology

    Current Research and Scholarly InterestsWe study the molecular events that give rise to the sensation of touch and temperature in C. elegans. To do this, we use a combination of quantitative behavioral analysis, genetics, in vivo electrophysiology, and heterologous expression of ion channels. We also collaborate with Pruitt's group in Mechanical Engineering to develop and fabricate novel devices for the study of sensory transduction.

  • Steven Goodman

    Steven Goodman

    Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy

    Current Research and Scholarly InterestsI am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.

  • Stuart Goodman, MD, PhD

    Stuart Goodman, MD, PhD

    The Robert L. and Mary Ellenburg Professor of Surgery and Professor, by courtesy, of Bioengineering

    Current Research and Scholarly InterestsAs an academic orthopaedic surgeon, my interests center on adult reconstructive surgery, arthritis surgery, joint replacement, biomaterials, biocompatibility, tissue engineering, mesenchymal stem cells. Collaborative clinical, applied and basic research studies are ongoing.

  • L. Henry Goodnough, MD, PhD

    L. Henry Goodnough, MD, PhD

    Assistant Professor of Orthopaedic Surgery

    BioDr. Goodnough is an orthopaedic surgeon who is fellowship-trained in orthopaedic traumatology. This specialty is dedicated to the care of patients with complex injuries to the body’s bones, joints, or tissues.

    Dr. Goodnough is a clinical instructor of orthopaedic surgery. He also holds a PhD degree, and his doctoral research focused on genetic mechanisms of early bone development.

    For each patient, he develops a personalized plan of care. His goals are to treat the patient’s injury, restore function, and help promote the best possible quality of life. His clinical interests include nonunions, periarticular fractures, fractures of the pelvis and acetabulum, and infections.

    Dr. Goodnough has conducted research on the role of skeletal stem cells in fracture healing. He also has investigated how cells function in fractures that have failed to heal (“nonunions”).

    He has co-authored articles on his research discoveries in the Journal of the American Academy of Orthopaedic Surgery, Journal of Orthopaedic Trauma, Journal of Bone and Mineral Research, and elsewhere. Topics include advances in surgical technique and technology.

    He also has contributed to chapters in the textbooks Surgery of the Hip, Skeletal Trauma of the Upper Extremity, and Operative Techniques in Orthopedic Trauma.

    Dr. Goodnough has presented the findings of his research at numerous national and regional conferences. They include meetings of the Orthopaedic Trauma Association, American Academy of Orthopaedic Surgeons, and Western Orthopaedic Association. Topics have included the effects of non-steroidal anti-inflammatory drugs on skeletal stem cells in fractures.

    Dr. Goodnough is a member of the American Academy of Orthopaedic Surgeons, Orthopaedic Trauma Association, and AO, the global network of doctors dedicated to the surgical treatment of trauma and musculoskeletal disorders.

  • Lawrence Tim Goodnough

    Lawrence Tim Goodnough

    Professor of Pathology and of Medicine (Hematology), Emeritus

    Current Research and Scholarly InterestsImproving blood utilization
    Promoting alternatives to blood transfusion
    Quality improvements